Search

everythinglearnresearchcommunity

for

Search:↓

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Eclipta alba leaf alkaloids may help treat HIV by inhibiting the virus's activity.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Raltegravir may cause hair loss in some patients.

34% of patients on hepatitis C treatment had reversible skin issues.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Ethylenthiourea is toxic to the liver and nervous system, especially with alcohol.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Indinavir and ritonavir therapy can cause reversible hair loss.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

Tangent screens help detect visual field defects from vigabatrin.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

The AVET system effectively delivers genes to human keratinocytes and may help treat skin diseases.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

The medication lopinavir-ritonavir may cause severe hair loss.

Supplemental testosterone may lower liver cancer risk in hepatitis C patients.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.